Patrick Cullinan, DO
Critical Care Medicine · San Antonio, TXNPI 1043389653
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Fisher Scientific Company L.L.C. accounts for 62.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $4,312 and has fallen 85.4% since, to $628 in 2025. Among critical care medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $256.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fisher Scientific Company L.L.C.$6K
- AbbVie$814
- AstraZeneca$548
- Kerecis Limited$300
- Actelion Pharmaceuticals US, Inc.$248
- Sobi, Inc$201
- plus $1K from 12 others
What the payments were for
- Speaking & faculty fees$4,70050%
- Travel & lodging$3153%
- Food & beverage$4,38746%
- Education$761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fisher Scientific Company L.L.C. | 7 | $5,952 |
| AbbVie | 7 | $814 |
| AstraZeneca(2 entities) | 5 | $548 |
| Kerecis Limited | 2 | $300 |
| Actelion Pharmaceuticals US, Inc. | 2 | $248 |
| Sobi, Inc | 2 | $201 |
| Stryker | 1 | $153 |
| Medtronic | 1 | $133 |
| Neurocrine Biosciences, Inc. | 1 | $128 |
| Abbott | 1 | $125 |
| Piramal Critical Care | 1 | $125 |
| Alcresta Therapeutics, Inc. | 1 | $122 |
| Bayer | 1 | $121 |
| Mylan Specialty L.p. | 1 | $120 |
| La Jolla Pharmaceutical Company | 1 | $115 |
| Paratek Pharmaceuticals, Inc. | 1 | $109 |
| Chiesi USA, Inc. | 1 | $88 |
| BTG International Inc. | 1 | $76 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Procalcitonin$5,952
- Kerecis SurgiClose$600
- Kerecis Omega3 Marigen$600
- GABLOFEN$500
- AVYCAZ$375
- UPTRAVI$248
- OPSUMIT$248
- ANDEXXA$218
- PHYSIO - LUCAS$153
- Kerecis GraftGuide$150
- Kerecis Omega3 SurgiClose$150
- LINQ II$133
- ONGENTYS$128
- AMPLATZER AMULET$125
- BRILINTA$125
- TEFLARO$125
- DALVANCE$125
- Gamifant$125
- SOLIRIS$122
- RELIZORB$122
How this compares
$9,478 in reported general payments places this provider in the 90th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in San Antonio
- Rachel GarvinSan Antonio$97K
- Adam GottulaSan Antonio$26K
- Holly KeytSan Antonio$14K
- Scott HagedornSan Antonio$13K
- Phillip MasonSan Antonio$9K
- Steven DavidoffPlano$364K
- William BartekAustin$284K
- Edwin ParsleyHouston$283K
- Hector PayanEl Paso$245K
- Bindu AkkantiHouston$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.